Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

Rang in Aktien #4296
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Aktienkurs
$2.42
Marktkapitalisierung
$3.62B
Veränderung (1 Tag)
-3.06%
Veränderung (1 Jahr)
-8.97%
Land
CN
Handel Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

Kategorie

Healthcare
Kursverlauf für Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Höchster Schlusskurs: $2.43 am 2026-10-01

Niedrigster Schlusskurs: $0.16 am 2003-03-01
Kursverlauf der Aktie von Zhejiang Huahai Pharmaceutical Co., Ltd. von 2003 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -3.88%
2025 -2.54%
2024 21.89%
2023 -28.55%
2022 -8.10%
2021 -38.22%
2020 124.56%
2019 37.85%
2018 -48.65%
2017 30.46%
2016 14.37%
2015 53.29%
2014 11.91%
2013 64.45%
2012 -5.96%
2011 -12.19%
2010 9.52%
2009 102.34%
2008 -28.32%
2007 82.10%
2006 48.93%
2005 -14.60%
2004 67.52%
2003 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$165.31 23.62%
DE
$40.45 43.11%
JP
$224.81 31.28%
CH
$18.43 -4.03%
IN